Humankind Investments’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Humankind Investments’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-13,631	Closed	-$486K	–	149
2023 Q1	$486K	Sell	13,631 -2,645	-16%	-$96K	0.2%	66
2022 Q4	$597K	Buy	16,276 +8,275	+103%	+$327K	0.26%	61
2022 Q3	$377K	Buy	8,001 +1,785	+29%	+$115K	0.18%	72
2022 Q2	$446K	Buy	6,216 +1,594	+34%	+$117K	0.21%	65
2022 Q1	$374K	Buy	4,622 +1,174	+34%	+$99.3K	0.15%	79
2021 Q4	$354K	Sell	3,448 -127	-4%	-$12.2K	0.45%	69
2021 Q3	$313K	Buy	3,575 +636	+22%	+$57.6K	0.48%	68
2021 Q2	$263K	Buy	+2,939	New	+$248K	0.47%	68

Other funds holding SYNH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

EIM

Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Humankind Investments's SYNH Position: Q2 2023 in Review

Humankind Investments sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2023, closing a stake of 13,631 shares — an estimated $486K sold.

Humankind Investments first reported a position in SYNH in Q2 2021 and held it in 8 quarters. The position peaked at $597K in Q4 2022. 317 funds tracked by Wall St. Rank hold SYNH as of Q2 2023.

Humankind Investments reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Humankind Investments sold 13,631 Syneos Health, Inc. Class A Common Stock shares in Q2 2023, an estimated $486K.
Humankind Investments first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2021 and held it in 8 quarters.
Humankind Investments's Syneos Health, Inc. Class A Common Stock position peaked at $597K in Q4 2022.
317 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2023.

Based on Humankind Investments's 13F filing for Q2 2023, filed 9 Aug 2023.